PMID: 11337366May 5, 2001Paper

Expression of a novel RNA-splicing factor, RA301/Tra2beta, in vascular lesions and its role in smooth muscle cell proliferation

The American Journal of Pathology
Y TsukamotoS Ogawa

Abstract

RA301/Tra2beta, a sequence-specific RNA-binding protein, was first cloned as a stress molecule in re-oxygenated astrocytes. In human vascular tissues, we have found enhanced RA301/Tra2beta expression in coronary artery with intimal thickening, and atherosclerotic aorta. Balloon injury to the rat carotid artery induced RA301/Tra2beta transcripts followed by expression of the antigen, which was detected in medial and neointimal vascular smooth muscle cells (VSMCs). In cultured VSMCs, hypoxia/re-oxygenation caused induction of RA301/Tra2beta and was accompanied by cell proliferation, both of which were blocked by the addition of either diphenyl iodonium, a NADPH oxidase inhibitor, PD98059, a mitogen-activated protein kinase kinase inhibitor, or antisense oligonucleotide for RA301/Tra2beta. Consistent with a link between RA301/Tra2beta and cell proliferation, platelet-derived growth factor also induced expression of RA301/Tra2beta in cultured VSMCS: These data suggest a possible role for RA301/Tra2beta in the regulation of VSMC proliferation, especially in the setting of hypoxia/re-oxygenation-induced cell stress.

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
Sep 1, 1992·The Journal of Clinical Investigation·S KogaD K Burns
Apr 1, 1992·Current Opinion in Cell Biology·A S Lee
Aug 1, 1991·Atherosclerosis·D W Crawford, D H Blankenhorn
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·D GordonS M Schwartz
Aug 1, 1986·International Journal of Radiation Oncology, Biology, Physics·C S Heacock, R M Sutherland
Nov 24, 1995·The Journal of Biological Chemistry·N MatsuoA Wanaka
May 9, 1995·Proceedings of the National Academy of Sciences of the United States of America·K KuwabaraJ Joseph-Silverstein
Jan 15, 1996·Circulation·Y ShiA Zalewski
Aug 20, 1996·Proceedings of the National Academy of Sciences of the United States of America·B DauwalderW Mattox
Nov 14, 1998·Brain Research. Molecular Brain Research·S Kiryu-SeoH Kiyama
Feb 26, 1999·The Journal of Biological Chemistry·K OzawaM Tohyama
Sep 24, 1999·The Journal of Clinical Investigation·K WalshA Gualberto
Oct 3, 1999·Physiological Reviews·C H Heldin, B Westermark
Dec 10, 1966·Nature·Y Nakata, S Shionoya

❮ Previous
Next ❯

Citations

Aug 21, 2013·Pathology, Research and Practice·Yoshitane TsukamotoSeiichi Hirota
Aug 13, 2013·International Journal of Cell Biology·Andrew BestDavid J Elliott
Jan 31, 2013·Journal of Gastroenterology·Keisuke KajitaKazuhito Rokutan
Nov 5, 2003·Genesis : the Journal of Genetics and Development·Emmanual UnniWilliam Mattox
May 26, 2004·The Journal of Biological Chemistry·Scott T ForrestColeen A McNamara
May 15, 2009·American Journal of Physiology. Cell Physiology·Keiko TakeoKazuhito Rokutan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.